Molecular imaging as a tool to investigate heterogeneity of advanced HER2-positive breast cancer and to predict patient outcome under trastuzumab emtansine (T-DM1): the ZEPHIR trial
Titel:
Molecular imaging as a tool to investigate heterogeneity of advanced HER2-positive breast cancer and to predict patient outcome under trastuzumab emtansine (T-DM1): the ZEPHIR trial
Auteur:
Gebhart, G. Lamberts, L.E. Wimana, Z. Garcia, C. Emonts, P. Ameye, L. Stroobants, S. Huizing, M. Aftimos, P. Tol, J. Oyen, W.J.G. Vugts, D.J. Hoekstra, O.S. Schröder, C.P. Menke-van der Houven van Oordt, C.W. Guiot, T. Brouwers, A.H. Awada, A. de Vries, E.G.E. Flamen, P.